Evidence map›Paper›PMID 42656604›Full record

ArticleNAR cancer2026

SNHG family lncRNAs promote Ewing sarcoma cell fitness through intronic snoRNA-guided rRNA modifications.

Marcela Briones-Martin-Del-Campo, Alex G Lee, Truc Dinh, Virginie Marchand, Yuri Motorin, Marta Román, Qiuli Bi, Stanley G Leung, Max A Horlbeck, Leanne C Sayles and 4 more

Abstract read
In one paragraph

Article in NAR cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Marcela Briones-Martin-Del-CampoDepartment of Pediatrics, University of California, San Francisco, CA 94158, United States.ORCID https://orcid.org/0000-0002-0401-5352
Alex G LeeDepartment of Pediatrics, University of California, San Francisco, CA 94158, United States.
Truc DinhDepartment of Pediatrics, University of California, San Francisco, CA 94158, United States.
Virginie MarchandEpitranscriptomics and RNA Sequencing Core Facility, Université de Lorraine, CNRS, INSERM, IBSLor (UAR2008/US40), Nancy F-54000, France.
Yuri MotorinIMoPA (UMR7365), CNRS, Université de Lorraine, Nancy F-54000, France.ORCID https://orcid.org/0000-0002-8018-334X
Marta RománDepartment of Pediatrics, University of California, San Francisco, CA 94158, United States.
Qiuli BiDepartment of Pediatrics, University of California, San Francisco, CA 94158, United States.
Stanley G LeungDepartment of Pediatrics, University of California, San Francisco, CA 94158, United States.
Max A HorlbeckDepartment of Pediatrics, Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0002-3875-871X
Leanne C SaylesDepartment of Pediatrics, University of California, San Francisco, CA 94158, United States.
Bo Kyung Alex SeongDepartment of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, United States.
Luke GilbertDepartment of Urology, University of California, San Francisco, CA 94158, United States.
Kimberly StegmaierDepartment of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, United States.ORCID https://orcid.org/0000-0003-0218-7895
E Alejandro Sweet-CorderoDepartment of Pediatrics, University of California, San Francisco, CA 94158, United States.ORCID https://orcid.org/0000-0002-9787-9351

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alan Ashworth · 1999 to 2026
$209.7M
Sweet-Cordero_Diversity Supplement_Due 03/30/18R01CA211657 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SWEET-CORDERO, ERIC ALEJANDRO · 2017 to 2021
$2.0M
Illumina NovaSeq 6000 Sequencing SystemS10OD028511 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHOW, ERIC D · 2020 to 2020
$583k
NCI NIH HHS P30 CA082103NCI NIH HHS R01 CA211657NIH HHS S10 OD028511
6 · The paper itself

Abstract

Over 90% of Ewing sarcomas (EWS) are driven by the EWS-FLI1 fusion oncoprotein. EWS-FLI1 acts as a pioneer transcription factor, altering the expression of hundreds of genes including many long non-coding RNAs (lncRNAs). The role of these lncRNAs in the oncogenesis of EWS is mostly unknown. We developed a CRISPR interference (CRISPRi) strategy to knock down expression of lncRNA loci expressed in EWS and evaluate their effect on proliferation

Indexed as

Bone NeoplasmsRNA, Long NoncodingRNA, Small NucleolarSarcoma, EwingAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansIntronsMiceOncogene Proteins, FusionProto-Oncogene Protein c-fli-1RNA-Binding Protein EWSRNA Processing, Post-TranscriptionalEWS-FLI fusion proteinOncogene Proteins, FusionProto-Oncogene Protein c-fli-1RNA-Binding Protein EWSRNA, Long NoncodingRNA, Small Nucleolar

Identifiers

PMID42656604
PMCPMC13507652

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.